Response to breast neoadjuvant systemic therapy (NAST) was longitudinaly monitored with Diffustion Tensor Imaging (DTI) pre and post therapy and evaluated in reference to post surgery histopatholgy results. A correlation was demonstrated between DTI residual tumor size and pathology size. Response in the various breast cancer subtypes was revealed by increased λ 1 values validated by a correlation with the pathological residual disease. DTI detected pCR in all breast subtypes with a good sensitivity and specificity
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords